Pfizer’s ‘Vaccine’ Explained: Its Effect Decreases Over Time


In a report to the U.S. Food and Drug Administration (FDA), Pfizer announced that the effectiveness of the mRNA-based coronavirus vaccine naturally diminishes over the months. According to the company, the vaccine loses efficacy by 3 percent each month. The USA is considering giving a third dose of vaccine to everyone because of this statistic.

Founded by Turkish scientists, BioNTech has developed one of the most effective vaccines against coronavirus. Pfizer, submitted a report to health authorities in the USA. This report on the effect of the vaccine over time revealed a very natural result. According to the report, mRNA-based coronavirus vaccine, loses its effect over time.

Making a very clear statement in the report submitted to the US Food and Drug Administration (FDA), Pfizer said, “of any variant independent somehow, the effect of the vaccine naturally diminishes over time. It would not be correct to say that the Delta variant reduces the effect of the vaccine.”, saying that it is natural for the effect of the vaccine to decrease, but that not associated with delta variant stressed.

Vaccine effectiveness decreases by 3 percent each month

The following statements were included in the statements made by Pfizer; “The protective effect of the vaccine decreases by 6 percent every two months. The protection rate of 96.2 percent when the full dose is vaccinated., it drops to 83.7 percent after four months.” So why did Pfizer submit such a report to the FDA? Is there a new development regarding the course of the epidemic?

RELATED NEWS

Exemplary Tomography Images of COVID-19 Patients with and Without Vaccination

The US has been considering whether to administer a third dose of mRNA vaccine for some time. discussing. The agency, which recently made an important decision, allowed those with weakened immune systems to receive a third dose of the vaccine. However, healthy individuals are also on the agenda to receive a third dose of vaccine. The incoming report is the third dose of the FDA. most likely to approve it reveals. If such a situation occurs, people who have passed 6 months after the second dose will be able to receive the third dose of vaccine. Of course, this decision taken in the USA will set a precedent, probably TurkeyIt should be said that such an application will be adopted in .

Source :
https://www.sozcu.com.tr/2021/saglik/pfizerdan-covid-19-asisi-aciklamasi-etkisi-zamanla-azalenen-6651851/